EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Relationship of fractional exhaled nitric oxide with blood eosinophilia in characterizing type-2 airway inflammation in treatment-naïve patients with chronic obstructive pulmonary disease

Riksoam Chatterjee, Mansi Gupta iD, Zia Hashim, Ajmal Khan iD, Alok Nath iD, Vikas Aggarwal iD

Monaldi Archives for Chest Disease · 2025

DOI: 10.4081/monaldi.2025.3315 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Monaldi Archives for Chest Disease, 2025. Verfasst von Riksoam Chatterjee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Eosinophilia, Fractional Exhaled Nitric Oxide Testing, Nitric Oxide. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fractional exhaled nitric oxide (FeNO), a sensitive and reproducible, non-invasive biomarker for type-2 (T2) inflammation in asthma, remains underutilized in chronic obstructive pulmonary disease (COPD). We investigated the potential role of FeNO and its relationship with blood eosinophilia in characterizing T2 airway inflammation in COPD. A single-center prospective observational study was conducted in 75 treatment-naïve adult patients with stable COPD and 75 age-sex-matched controls. The Global Initiative for Chronic Obstructive Lung Disease criteria were used for the diagnosis of COPD. FeNO levels were compared with clinico-radiological features, pulmonary functions, and other markers of T2 inflammation in COPD. Participants in the COPD subgroup had a median age of 62 (55.0, 69.0) years with a male predominance (77.3%). The median FeNO value was 27.0 ppb (19.0, 39.0) in COPD and 14.0 ppb (10.0, 20.0) in controls (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveEosinophiliaFractional Exhaled Nitric Oxide TestingNitric OxideInflammationHumansMaleFemaleAgedProspective StudiesMiddle AgedBiomarkersRespiratory Function TestsCase-Control StudiesExhalationBreath TestsEosinophils

Stichwörter der Autor:innen

Fractional exhaled nitric oxidechronic obstructive pulmonary diseaseeosinophilic inflammationtype-2 airway inflammation

Substanzen

BiomarkersNitric Oxide

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow.
  • Department of Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow.

ORCID-Profile: Mansi Gupta, Ajmal Khan, Alok Nath, Vikas Aggarwal

Zitieren

APA

Chatterjee, R., Gupta, M., Hashim, Z., Khan, A., Nath, A., & Aggarwal, V. (2025). Relationship of fractional exhaled nitric oxide with blood eosinophilia in characterizing type-2 airway inflammation in treatment-naïve patients with chronic obstructive pulmonary disease. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2025.3315

Vancouver

Chatterjee R, Gupta M, Hashim Z, Khan A, Nath A, Aggarwal V. Relationship of fractional exhaled nitric oxide with blood eosinophilia in characterizing type-2 airway inflammation in treatment-naïve patients with chronic obstructive pulmonary disease. Monaldi Archives for Chest Disease. 2025. doi:10.4081/monaldi.2025.3315

BibTeX
@article{Chatterjee2025,
  author = {Chatterjee, Riksoam and Gupta, Mansi and Hashim, Zia and Khan, Ajmal and Nath, Alok and Aggarwal, Vikas},
  title = {Relationship of fractional exhaled nitric oxide with blood eosinophilia in characterizing type-2 airway inflammation in treatment-naïve patients with chronic obstructive pulmonary disease},
  journal = {Monaldi Archives for Chest Disease},
  year = {2025},
  doi = {10.4081/monaldi.2025.3315}
}
Kostenlos starten →